Articles

Management of dyslipidaemia in patients with comorbidities – facing the challenge Value and limitations of lipid lowering drugs in liver disease Effects/Interactions of lipid-lowering agents on/with the liver

Frühwald L, Fasching P, Dobrev D, et al.

Journal: 

Eur Heart J Cardiovasc Pharmacother

First published: December 24, 2024  DOI: 10.1093/ehjcvp/pvae095